2009China Modern MedicineRequires access

Experience on treatment of advanced age and danger benign prostatic hyperplasia(BPH) patients with transurethral plasmakinetic resection of prostate

Qian Xu

Open publisher page 0 citations

Abstract

Objective:To evaluate the effect and safety of surgical treatment of transurethral plasmakinetic resection of prostate (TUPKVP)in advanced age and danger of benign prostatic hyperplasia (BPH) patients.Methods:61 cases of BPH were treated by transurethral plasmakinetic resection of prostate (TUPKVP).Results:The mean prostatic weight was 53 g and blood loss 30 to 100 ml.No TURS and no real urinary incontinence and no blood transfusion.All cases obtained un obstructed micturition after treatment.Following up 3 to 12 months,their international prostate symptom score (IPSS) were significantly improved by TUPKVP.Conclusion:TUPKVP is a safe and effective way in the treatment of advanced age and danger benign prostatic hyperplasia(BPH) patients.

About this research paper

What this paper is about

Objective:To evaluate the effect and safety of surgical treatment of transurethral plasmakinetic resection of prostate (TUPKVP)in advanced age and danger of benign prostatic hyperplasia (BPH) patients.Methods:61 cases of BPH were treated by transurethral plasmakinetic resection of prostate (TUPKVP).Results:The mean prostatic weight was 53 g and blood loss 30 to 100 ml.No TURS and no real urinary incontinence and no blood transfusion.All cases obtained un obstructed micturition after treatment.Following up 3 to 12 months,their international prostate symptom score (IPSS) were significantly improved by TUPKVP.Conclusion:TUPKVP is a safe and effective way in the treatment of advanced age and danger benign prostatic hyperplasia(BPH) patients.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective:To evaluate the effect and safety of surgical treatment of transurethral plasmakinetic resection of prostate (TUPKVP)in advanced age and danger of benign prostatic hyperplasia (BPH) patients.Methods:61 cases of BPH were treated by transurethral plasmakinetic resection of prostate (TUPKVP).Results:The mean prostatic weight was 53 g and blood loss 30 to 100 ml.No TURS and no real urinary incontinence and no blood transfusion.All cases obtained un obstructed micturition after treatment.Following up 3 to 12 months,their international prostate symptom score (IPSS) were significantly improved by TUPKVP.Conclusion:TUPKVP is a safe and effective way in the treatment of advanced age and danger benign prostatic hyperplasia(BPH) patients.

Key concepts: Medicine, Hyperplasia, Urology, Prostate, Transurethral resection of the prostate, Urination, International Prostate Symptom Score, Blood loss

Related papers

Back to paper searchBrowse research topicsOriginal source
Experience on treatment of advanced age and danger benign prostatic hyperplasia(BPH) patients with transurethral plasmakinetic resection of prostate — Research Paper | ScholarLens